What is Indegene's business focus and history?

Indegene is a publicly traded company based in Bengaluru, India, founded in 1998 by Rajesh Nair, Manish Gupta, Sanjay Parikh, Anand Kiran, and Gaurav Kapoor. It operates as a digital-first life sciences commercialization company, providing services to biopharmaceutical, emerging biotech, and medical device companies. Indegene has raised $200 million in funding from investors including The Carlyle Group and Brighton Park Capital. The company has 5,081 employees and offices in multiple countries, including the United States, United Kingdom, China, Singapore, and Canada. Its top competitors include companies like Syneos Health, Parexel, and ICON plc.

Indegene Corporate Details & Core Services

Indegene is a digital-first life sciences commercialization company that helps biopharmaceutical, emerging biotech, and medical device companies develop products, bring them to market, and grow their impact through the lifecycle in a more effective, efficient, and modern way.

Indegene Contact Information & Official Links

Website https://www.indegene.com
Social    
Email id compliance.officer@indegene.com
Phone number +91 80 4674 4567
Head office address Bengaluru, Karnataka, India
Tags Life Sciences Healthcare Digital Transformation Pharmaceutical Consulting Medical Affairs

What are Indegene's Key Business Metrics & Stats?

No of employees 5081
Founded year 1998
Type public
SAICS CODE 8731
NAICS Code 541714
Industry Life Sciences
Location Bengaluru, Karnataka, India
Subsidiary Company medsn.com, medcases.com, aptilon.com, totaltherapeuticmanagement.com, dtassociates.com, mme.com
Stock Name INDGN (NSE), 544172 (BSE)
Pricing Strategy Custom Solutions, Subscription-Based Services, Project-Based Pricing
Indegene INDGN (NSE), 544172 (BSE) Firmographic Snapshot 2026 1998 Founded Year 5081 Global Employees India Headquarters LifeSciences Industry Public Type Verified by DexterAgent.ai

How much funding has Indegene raised to date?

Name Description
Funding Amount USD 200 Million
Stage Private Equity
Latest Valuation 220 Million (USD)
Lead Investor The Carlyle Group
Investors The Carlyle Group, Brighton Park Capital

What are Indegene's Core Products?

Name Description
Cortex A fit-for-purpose Generative AI platform verticalized for the life sciences industry, enabling life sciences leaders to adopt and scale transformative technology with enterprise-grade governance.

What are the latest developments at Indegene?

Date Type Description
December, 2024 Award Indegene ranked among the Top 100 Companies for Women to Work in India by AVTAR for the eighth consecutive year.
August, 2025 Product Launch Indegene launched Cortex, a Generative AI platform tailored for the life sciences industry.

What industry awards and recognitions has Indegene received?

Date Type Description
December, 2024 Recognition Ranked among the Top 100 Companies for Women to Work in India by AVTAR
November, 2024 Award Named a Front-Runner in GenAI Life Sciences Market Adoption by Everest Group

Indegene VS Syneos Health VS Parexel VS ICON plc VS Piramal Group VS IQVIA : 2026 Comparison

Feature Indegene Syneos Health Parexel ICON plc Piramal Group IQVIA
Core Strengths Cortex Clinical Development Services, Commercial Delivery, Consulting Clinical Trial Management, Regulatory Consulting, Real World Evidence, Medical Communications Clinical & Scientific Operations, Decentralised Clinical Trials, Laboratory Solutions Piramal Pharma Solutions, Piramal Finance, Piramal Realty IQVIA CORE, IQVIA Connected Intelligence
Founded Year 1998 2017 1982 1990 1948 2016
Stock Name/Ticker INDGN (NSE), 544172 (BSE) ICLR (NASDAQ) IQV (NYSE)
Type public private private public private public
Global Employees 5081 29000 24000 41900 15000 88000
Revenue (Annual) $332.4 Million(2025) $5.4 Billion(2022) $2.3 Billion(2017) $8.3 Billion(2024) $2 Billion(2025) $15.4 Billion(2024)
Headquarters Bengaluru, Karnataka, India Morrisville, North Carolina, United States Raleigh, North Carolina, United States Dublin, Ireland Mumbai, Maharashtra, India Durham, North Carolina, United States
Latest Valuation $220 Million $7.1 Billion $8.5 Billion $20.4 Billion $10 Billion $15.4 Billion
LATEST REVENUE (TRILLIONS USD) EMPLOYEE COUNT (THOUSANDS) INNOVATORS VISIONARIES DISRUPTORS GIANTS Syneos Health 5.4 | 29000 Parexel 2.3 | 24000 ICON plc 8.3 | 41900 Piramal Group 2 | 15000 Competitive Landscape 2026 DexterAgent.ai
Name Description
Legal Name Indegene Limited
Cin number U73100KA1998PLC102040
GST number
Registration number U73100KA1998PLC102040

Who is in Indegene's executive leadership team?

Name Designation
CEO Manish Gupta
Chief Financial Officer Suhas Prabhu
Chief Technology Officer Tarun Mathur
Executive Vice President of Global Operations Anand Kiran
Executive Director and Executive Vice President Dr. Sanjay Suresh Parikh

Where are Indegene's primary office locations?

City Country
Princeton United States
London United Kingdom
Shanghai China
Singapore Singapore
Dorval Canada
Oakville Canada

What are the current business signals and market intelligence for Indegene?

Spending next 3 months Digital Transformation, AI Integration, Global Expansion
Pain points Regulatory Compliance, Market Access, Digital Transformation, Data Management
Sales motion Enterprise Sales, Consultative Selling, Solution Selling
Buyer Persona Chief Medical Officers, Regulatory Affairs Directors, Commercial Operations Managers
Type of customer Biopharmaceutical Companies, Emerging Biotech Firms, Medical Device Manufacturers
Key customer domain pfizer.com, novartis.com, merck.com, johnsonandjohnson.com, gsk.com
Annual ACV 500000

What is Indegene's annual revenue history?

Year Revenue (USD)
2025 332.4 Million

What are Indegene's risk management and compliance ratings?

GDPR RIsk Yes
Privacy Risk Yes
Company Ratings 3.3
Glassdoor Rating 3.3

What are Indegene's business model and service classifications?

Saas Yes
Offline Stores No
Service Yes
Ecommerce No
Exporter Yes
Mobile App No
Retail No
B2B Yes
B2C No
Manufacturing No
Wholesale No
Importer No
Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)

 

Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)